Gapping down
In reaction to earnings/guidance:
- ROST -27.7%, BAH -4.8%, DE -3%, AMAT -1.1%
Other news:
- FHTX -15.5% (provides update on Phase 1 study of FHD-286; FDA initiates partial clinical hold)
- BURL -11.4% (in sympathy with weak ROST earnings)
- TJX -3.7% (in sympathy with weak ROST earnings)
- ATRA -3.1% (ATRA says Bayer (BAYRY) intends to end licensing agreement for next-gen mesothelin-directed CAR T-cell therapies)
- KSS -2.3% (Macellum Issues Statement Regarding the Kohl's Board's Apparent Breach of Fiduciary Duty and Failure to Disclose Material Information Prior to 2022 Annual Meeting)
Analyst comments:
- PSTG -1.9% (downgraded to Neutral from Buy at BofA Securities)
- HPE -1.4% (downgraded to Neutral from Buy at BofA Securities)
- WIX -1% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- FRPT -0.7% (downgraded to Neutral from Overweight at Atlantic Equities)